A Manufacturer’s Guide to Critical Drug Pricing and Reimbursement Considerations when Launching New Products

Sharon Small
Director, Counsel – Market Access-Gov.t Pricing and Policy
Novartis

Rujul H. Desai
Partner
Covington & Burling LLP
- Examining pricing and reimbursement considerations form the pre-commercialization through product launch stages
- Analyzing the procedural approaches to set a launch price for a new drug
- Understanding legal, policy, and reputational risks around price setting
- Ensuring transparency for the pricing process
- Considering the role of traditional and non-traditional functions in setting price
- Accessing government and commercial programs to secure appropriate coding, coverage, and reimbursement for new products
- Examining how the IRA is impacting the pricing of new products